多目标天然化合物服NETosis:癌症和炎症疾病的翻译策略
Wentao Jia1, Jinbo Zhang2, Yan Shang3
1Department of General Practice, Changhai Hospital, Naval Medical University, Shanghai, 200433, China; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, 200043, China.
中性粒细胞外细胞陷 (NETs) 对于防御至关重要,但在失调时驱动疾病. 天然化合物在调节NETosis以获得治疗益处方面表现有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 中性粒细胞外细胞陷 (NETs) 参与宿主防御,也参与病变发生.
- 失调的NETosis有助于慢性炎症,血栓形成和癌症转移.
- NETosis调制为各种疾病提供了治疗机会.
研究的目的:
- 审查NETosis的分子机制.
- 突出NETosis在自身免疫性疾病,败血症和癌症中的病理作用.
- 探索自然化合物作为NETosis的调节剂.
主要方法:
- 关于NETosis机制和病理学的文献综述.
- 针对NETosis途径的自然化合物的分析.
- 关于药物发现的高通量分子对接策略的建议.
主要成果:
- 网有双重作用,有助于宿主防御和疾病.
- 自然化合物可以抑制NETosis信号传递,同时保持抗菌功能.
- 一个计算策略可以识别针对NETosis的新型自然产品.
结论:
- 自然化合物为NET驱动的疾病提供了一个有希望的治疗途径.
- 了解NETosis机制是开发向治疗的关键.
- 进一步的研究可以利用计算方法来发现天然产品药物.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drugs that Destabilize Microtubules
Non-Canonical Wnt Signaling Pathways
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
